Massive Transfusion in Trauma Patient Registry
1 other identifier
observational
500
1 country
1
Brief Summary
The early use of blood products as a part of Massive Transfusion Protocol (MTP) during trauma resuscitation has been increasingly supported by providers and backed by the literature. However, the incidence of hypocalcemia during MTP has also been recorded and continues to be studied as an exacerbating factor in coagulopathy during trauma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 13, 2023
CompletedFirst Submitted
Initial submission to the registry
November 13, 2023
CompletedFirst Posted
Study publicly available on registry
November 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 13, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 13, 2025
CompletedJanuary 18, 2024
January 1, 2024
1 year
November 13, 2023
January 16, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Establish a data set that will be permissive of quality improvement studies/observations specific to MTP in the trauma patient.
This data repository will serve as a means to aggregate and analyze best practices as relative to MTP in the trauma patient, with specific interest in component best practices, whole blood protocols, and electrolyte/metabolite replacement.
5 YEARS
Interventions
This data repository will serve as a means to aggregate and analyze best practices as relative to MTP in the trauma patient, with specific interest in component best practices, whole blood protocols, and electrolyte/metabolite replacement
Eligibility Criteria
≥18 years old * Included in the MDMC trauma registry * Flagged for MTP activation and/or \>1U blood product recorded in the first 24 hours
You may qualify if:
- ≥18 years old
- Included in the Methodist dallas medical center(MDMC) trauma registry
- Flagged for MTP activation and/or \>1unit(U) blood product recorded in the first 24 hours
You may not qualify if:
- \<18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Conner McDaniel, MD
Methodist Midlothian Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2023
First Posted
November 18, 2023
Study Start
July 13, 2023
Primary Completion
July 13, 2024
Study Completion
July 13, 2025
Last Updated
January 18, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
- Time Frame
- 2 years
Study data or any protected health information will not be shared with anyone that is not delegated to the study. The PI is committed to disseminate research results in a timely fashion. Sharing of results generated by the data analysis during the course of the project will be through presentation at national scientific meetings and/or publication in open access journals